Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis

doi:10.3748/wjg.15.5983

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3135)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

356

HTML

2515

Figures (1-5)

149

Tables (1-4)

115

Sum=3135

Dec 21, 2009 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (78)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 21, 2009; 15(47): 5983-5991
Published online Dec 21, 2009. doi: 10.3748/wjg.15.5983

Full Size Figure Download Figure

Figure 1 Postoperative survival rate in neoadjuvant chemoradiotherapy and surgery compared with surgery alone. A: One-year survival; B: Three-year survival; C: Five-year survival. CRT + S: Neoadjuvant chemoradiotherapy and surgery; S: Surgery; OR: Odds ratio; CI: Confidence interval.

Citation: Jin HL, Zhu H, Ling TS, Zhang HJ, Shi RH. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis. World J Gastroenterol 2009; 15(47): 5983-5991
URL: https://www.wjgnet.com/1007-9327/full/v15/i47/5983.htm
DOI: https://dx.doi.org/10.3748/wjg.15.5983